Form 4 filed by Froimson Mark
Froimson Mark filed this Form 4 on PCRX (Pacira BioSciences, Inc.) with 11 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-17 21:36:23 UTC.
- Accession
- 0001628280-26-074529
- Filer
- CIK 1709050
- Filed
- 2026-11-17
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: PCRX · Pacira BioSciences, Inc. (CIK 1396814)
- Froimson Mark director
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-17 | U | -20,136 | $36.5 | 6,405 | D |
| Common Stock | 2026-11-17 | D returned to the issuer | -6,405 | $36.5 | 0 | D |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -4,693 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -8,437 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -8,027 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -7,626 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -8,225 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -12,925 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -11,279 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -10,891 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -8,144 | 0 | D |